Home > Browse Issues > Vol.36 No.11

Establishment of a Highly Efficient Megakaryocytes Differentiation Model from Human Embryonic Stem Cells


Gao Jie1#, Yang Yiqing1,2#, Pang Sulei1, Liu Xin1, Lu Lisha3, Lei Xiaohua4, Xiong Tao3, Wang Hongtao1,Ma Feng5, Zhou Jiaxi1*
1State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China; 2Hebei North University, Faculty of Medical Laboratory Sciences,ZhangJiaKou 075000, China; 3College of Life Sciences, Yangtze University, Jingzhou 434025,China; 4Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China; 5Institute of Blood Transfusion, Chinese Academy of Medical Sciences & Peking Union Medical College, Chengdu 610052, China
Abstract: Human embryonic stem cells (hESCs) have unlimited proliferative capacity and are able to differentiate into all mature blood cell types including megakaryocytes. Hence, establishment of a highly efficient megakaryocytes differentiation model from hESCs may shed light on solving the problem of limited platelet sourcein clinical applications. Herein, we applied a model of hESCs co-cultured with mAGM-S3 stromal cell line for hematopoietic differentiation. In this model, we could obtain abundant “cobblestone-like” (CD43+CD45+cells) hematopoietic progenitor cells on the differentiation of day 14. Moreover, we isolated “cobblestone-like” hematopoietic progenitor cells and induced these cells to differentiate into megakaryocytes by adding cytokines, like SCF,
    TPO, IL-6, IL-3, FLt-3 and IL-11 by stages in serum free medium. Our research showed that the proportion of CD41a+ cells could reach 48.5%, and the proportion of CD42b+ cells could reach 30.0% on the differentiation of day 3. In addition, cells on the differentiation of day 6 showed characteristic of megakaryocytes by Wright-Giemsa staining. In conclusion, our research has preliminarily established a highly efficient megakaryocytes differentiation model from human embryonic stem cells, which provides a basis for obtaining plenty of megakaryocytes in vitro.


CSTR: 32200.14.cjcb.2014.11.0003